| Name | Title | Contact Details |
|---|
The Simply Good Foods Company, or “Simply Good Foods”, is the company created by the business combination of Conyers Park Acquisition Corp. and Atkins Nutritionals, Inc. Simply Good Foods will look to expand its platform through investment opportunities in the snacking space and broader food category. Over time, Simply Good Foods will look to become a portfolio of brands that bring simple goodness, happiness and positive experiences to consumers and their families. Simply Good Foods` common stock and warrants are listed on the NASDAQ stock exchange under the symbols “SMPL” and “SMPL.W”, respectively.
Labyrinth Health Care Group is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orgain, Inc. was founded by Andrew Abraham M.D. in 2008 . Orgain is the world's first organic drinkable meal on-the-go and is used by physicians, top nutritionists, professional athletes, and health conscious consumers across the nation. Orgain is nationally distributed at Whole Foods, Wegman's, Walgreens, CVS, Rite-Aid, Sprouts, Vitamin Shoppe, Mother's Market, Fairway Markets and many more -- over 15,000 retailers!
One of our nation’s most pressing challenges is the rising cost and affordability of healthcare. At Equian, our efforts are dedicated to addressing this challenge. We provide solutions that ensure each healthcare interaction is paid accurately and at the lowest possible cost. We have a proven system to reduce healthcare cost through proprietary data analytics coupled with deep domain expertise. Once we have aligned with you and analyzed all of the data, we provide integrated payment integrity solutions that eliminate unnecessary spending.
AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering and developing targeted therapies designed to provide substantial impact in patients` lives with clear unmet medical needs. AVEO`s proprietary Human Response PlatformTM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics.